Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 219
Filter
2.
Br J Dermatol ; 183(3): 462-470, 2020 09.
Article in English | MEDLINE | ID: mdl-31989580

ABSTRACT

BACKGROUND: Occupational hand dermatitis poses a serious risk for nurses. OBJECTIVES: To evaluate the clinical and cost-effectiveness of a complex intervention in reducing the prevalence of hand dermatitis in nurses METHODS: This was a cluster randomized controlled trial conducted at 35 hospital trusts, health boards or universities in the UK. Participants were (i) first-year student nurses with a history of atopic conditions or (ii) intensive care unit (ICU) nurses. Participants at intervention sites received access to a behavioural change programme plus moisturizing creams. Participants at control sites received usual care. The primary outcome was the change of prevalent dermatitis at follow-up (adjusted for baseline dermatitis) in the intervention vs. the control group. Randomization was blinded to everyone bar the trials unit to ensure allocation concealment. The trial was registered on the ISRCTN registry: ISRCTN53303171. RESULTS: Fourteen sites were allocated to the intervention arm and 21 to the control arm. In total 2040 (69·5%) nurses consented to participate and were included in the intention-to-treat analysis. The baseline questionnaire was completed by 1727 (84·7%) participants. Overall, 789 (91·6%) ICU nurses and 938 (84·0%) student nurses returned completed questionnaires. Of these, 994 (57·6%) had photographs taken at baseline and follow-up (12-15 months). When adjusted for baseline prevalence of dermatitis and follow-up interval, the odds ratios (95% confidence intervals) for hand dermatitis at follow-up in the intervention group relative to the controls were 0·72 (0·33-1·55) and 0·62 (0·35-1·10) for student and ICU nurses, respectively. No harms were reported. CONCLUSIONS: There was insufficient evidence to conclude whether our intervention was effective in reducing hand dermatitis in our populations. Linked Comment: Brans. Br J Dermatol 2020; 183:411-412.


Subject(s)
Dermatitis, Occupational , Eczema , Cost-Benefit Analysis , Dermatitis, Occupational/epidemiology , Dermatitis, Occupational/prevention & control , Hand , Humans , State Medicine , Surveys and Questionnaires
4.
Clin Microbiol Infect ; 25(1): 13-19, 2019 Jan.
Article in English | MEDLINE | ID: mdl-30414817

ABSTRACT

OBJECTIVE: To develop a consensus-based set of generic competencies in antimicrobial prescribing and stewardship for European prescribers through a structured consensus procedure. METHODS: The RAND-modified Delphi procedure comprised two online questionnaire rounds, a face-to-face meeting between rounds, and a final review. Our departure point was a set of competencies agreed previously by consensus among a UK multi-disciplinary panel, and which had been subsequently revised through consultation with ESCMID Study Group representatives. The 46 draft competency points were reviewed by an expert panel consisting of specialists in infectious diseases and clinical microbiology, and pharmacists. Each proposed competency was assessed using a nine-point Likert scale, for relevance as a minimum standard for all independent prescribers in all European countries. RESULTS: A total of 65 expert panel members participated, from 24 European countries (one to six experts per country). There was very high satisfaction (98%) with the final competencies set, which included 35 competency points, in three sections: core concepts in microbiology, pathogenesis and diagnosing infections (11 points); antimicrobial prescribing (20 points); and antimicrobial stewardship (4 points). CONCLUSIONS: The consensus achieved enabled the production of generic antimicrobial prescribing and stewardship competencies for all European independent prescribers, and of possible global utility. These can be used for training and can be further adapted to the needs of specific professional groups.


Subject(s)
Antimicrobial Stewardship , Clinical Competence , Consensus , Drug Prescriptions/standards , Anti-Bacterial Agents/administration & dosage , Curriculum , Drug Prescriptions/statistics & numerical data , Education , Europe , Professional Competence
5.
Clin Microbiol Infect ; 25(5): 562-569, 2019 May.
Article in English | MEDLINE | ID: mdl-30076978

ABSTRACT

BACKGROUND: Antimicrobials are among the most frequently prescribed drugs in long-term care facilities (LTCFs). Implementation of antimicrobial stewardship programmes (ASPs) is often challenging because of scarce data in this setting. OBJECTIVES: This narrative review aimed to provide data about antibiotic consumption in LTCFs and the need, implementation, and organization of ASPs in this setting. SOURCE: PubMed was searched for studies assessing antimicrobial consumption and implementation of ASPs in LTCFs. The search was restricted to articles published in English in the last 10 years. Experts belonging to the ESCMID Study Group for Infections in the Elderly (ESGIE) reviewed the selected studies and evaluated the studies on ASPs according to the GRADE approach. Moreover, the quality of reporting has been assessed according to TREND and CONSORT checklists for quasi-experimental and cluster randomized clinical trials (cRCT), respectively. CONTENT: Data on antibiotic consumption in LTCFs show great variability in LTCFs across and within countries. Reasons for this variability are difficult to analyse because of the differences in the types of LTCFs, their organization, and the population cared-for in the different LTCFs. However, studies show that the use of antibiotics among elderly patients in LTCFs, especially in cases of asymptomatic bacteriuria and influenza-like syndromes, is often inappropriate. High-quality cRCTs and low to moderate quality quasi-experimental studies show that educational interventions direct at nurse and physicians are effective in reducing unnecessary antibiotic prescriptions. IMPLICATIONS: There is an urgent need for ASPs tailored for LTCFs. Multifaceted organized educational interventions, involving both clinicians and nursing staff, should be advocated and require institutional intervention by health authorities. Future studies assessing the impact of well-defined ASPs in LTCFs should produce compelling evidence in this setting.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Antimicrobial Stewardship/organization & administration , Cross Infection/drug therapy , Drug Utilization/statistics & numerical data , Long-Term Care/methods , Aged , Aged, 80 and over , Female , Humans , Male
6.
J Hosp Infect ; 101(3): 248-256, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30036635

ABSTRACT

BACKGROUND: In low- and middle-income countries (LMICs), the burden of healthcare-associated infections (HCAIs) is not known due to a lack of national surveillance systems, standardized infection definitions, and paucity of infection prevention and control (IPC) organizations and legal infrastructure. AIM: To determine the status of IPC bundle practice and the most frequent interventional variables in LMICs. METHODS: A questionnaire was emailed to Infectious Diseases International Research Initiative (ID-IRI) Group Members and dedicated IPC doctors working in LMICs to examine self-reported practices/policies regarding IPC bundles. Responding country incomes were classified by World Bank definitions into low, middle, and high. Comparison of LMIC results was then made to a control group of high-income countries (HICs). FINDINGS: This survey reports practices from one low-income country (LIC), 16 middle-income countries (MICs) (13 European), compared to eight high-income countries (HICs). Eighteen (95%) MICs had an IPC committee in their hospital, 12 (63.2%) had an annual agreed programme and produced an HCAI report. Annual agreed programmes (87.5% vs 63.2%, respectively) and an annual HCAI report (75.0% vs 63.2%, respectively) were more common in HICs than MICs. All HICs had at least one invasive device-related surveillance programme. Seven (37%) MICs had no invasive device-related surveillance programme, six (32%) had no ventilator-associated pneumonia prevention bundles, seven (37%) had no catheter-associated urinary tract infection prevention bundles, and five (27%) had no central line-associated bloodstream infection prevention bundles. CONCLUSION: LMICs need to develop their own bundles with low-cost and high-level-of-evidence variables adapted to the limited resources, with further validation in reducing infection rates.


Subject(s)
Critical Care/methods , Cross Infection/prevention & control , Infection Control/methods , Cross-Sectional Studies , Developing Countries , Health Services Research , Humans , Surveys and Questionnaires
7.
Clin Microbiol Infect ; 22(9): 812.e9-812.e17, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27373529

ABSTRACT

We aimed to assess the current status of infectious diseases (ID), clinical microbiology (CM) and infection control (IC) staffing in hospitals and to analyse modifiers of staffing levels. We conducted an Internet-based survey of European Society of Clinical Microbiology and Infectious Diseases members and affiliates, collecting data on hospital characteristics, ID management infrastructure, ID/IC-related activities and the ratio of physicians per 100 hospital beds. Regression analyses were conducted to examine factors associated with the physician-bed ratio. Five hundred sixty-seven hospital responses were collected between April and June 2015 from 61 countries, 81.2% (384/473) from Europe. A specialized inpatient ward for ID patients was reported in 58.4% (317/543) of hospitals. Rates of antibiotic stewardship programmes (ASP) and surveillance activities in survey hospitals were high, ranging from 88% to 90% for local antibiotic guidelines and 70% to 82% for programmes monitoring hospital-acquired infections. The median ID/CM/IC physician per 100 hospital beds ratio was 1.12 (interquartile range 0.56-2.13). In hospitals performing basic ASP and IC (including local antibiotic guidelines and monitoring device-related or surgical site infections), the ratio was 1.21 (interquartile range 0.57-2.14). Factors independently associated with higher ratios included compliance with European Union of Medical Specialists standards, smaller hospital size, tertiary-care institution, presence of a travel clinic, beds dedicated to ID and a CM unit. More than half of respondents estimated that additional staffing is needed for appropriate IC or ID management. No standard of physician staffing for ID/CM/IC in hospitals is available. A ratio of 1.21/100 beds will serve as an informed point of reference enabling ASP and infection surveillance.


Subject(s)
Communicable Disease Control , Communicable Diseases/epidemiology , Hospitals , Infection Control/organization & administration , Microbiology/organization & administration , Europe/epidemiology , Female , Geography , Health Personnel , Humans , Internet , Male , Surveys and Questionnaires , Workforce
8.
Aust Vet J ; 93(11): 387-93, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26503532

ABSTRACT

BACKGROUND: Avian influenza viruses (AIVs) are found worldwide in numerous bird species, causing significant disease in gallinaceous poultry and occasionally other species. Surveillance of wild bird reservoirs provides an opportunity to add to the understanding of the epidemiology of AIVs. METHODS: This study examined key findings from the National Avian Influenza Wild Bird Surveillance Program over a 5-year period (July 2007-June 2012), the main source of information on AIVs circulating in Australia. RESULTS: The overall proportion of birds that tested positive for influenza A via PCR was 1.9 ± 0.1%, with evidence of widespread exposure of Australian wild birds to most low pathogenic avian influenza (LPAI) subtypes (H1-13, H16). LPAI H5 subtypes were found to be dominant and widespread during this 5-year period. CONCLUSION: Given Australia's isolation, both geographically and ecologically, it is important for Australia not to assume that the epidemiology of AIV from other geographic regions applies here. Despite all previous highly pathogenic avian influenza outbreaks in Australian poultry being attributed to H7 subtypes, widespread detection of H5 subtypes in wild birds may represent an ongoing risk to the Australian poultry industry.


Subject(s)
Influenza in Birds/epidemiology , Influenza in Birds/virology , Animals , Animals, Wild/blood , Animals, Wild/virology , Antibodies, Viral , Australia/epidemiology , Birds , Feces/virology , Geography , Influenza A virus/isolation & purification , Influenza in Birds/blood , Linear Models , Oropharynx/virology , Polymerase Chain Reaction , Population Surveillance
9.
Clin Microbiol Infect ; 21(12): 1047-51, 2015 Dec.
Article in English | MEDLINE | ID: mdl-26417851

ABSTRACT

Hand hygiene is considered to be the most effective way of preventing microbial transmission and healthcare-associated infections. The use of alcohol-based hand rubs (AHRs) is the reference standard for effective hand hygiene. AHR consumption is a valuable surrogate parameter for hand hygiene performance, and it can be easily tracked in the healthcare setting. AHR availability at the point of care ensures access to optimal agents, and makes hand hygiene easier by overcoming barriers such as lack of AHRs or inconvenient dispenser locations. Data on AHR consumption and availability at the point of care in European hospitals were obtained as part of the Prevention of Hospital Infections by Intervention and Training (PROHIBIT) study, a framework 7 project funded by the European Commission. Data on AHR consumption were provided by 232 hospitals, and showed median usage of 21 mL (interquartile range (IQR) 9-37 mL) per patient-day (PD) at the hospital level, 66 mL/PD (IQR 33-103 mL/PD) at the intensive-care unit (ICU) level, and 13 mL/PD (IQR 6-25 mL/PD) at the non-ICU level. Consumption varied by country and hospital type. Most ICUs (86%) had AHRs available at 76-100% of points of care, but only approximately two-thirds (65%) of non-ICUs did. The availability of wall-mounted and bed-mounted AHR dispensers was significantly associated with AHR consumption in both ICUs and non-ICUs. The data show that further improvement in hand hygiene behaviour is needed in Europe. To what extent factors at the national, hospital and ward levels influence AHR consumption must be explored further.


Subject(s)
Anti-Infective Agents, Local/administration & dosage , Hand Disinfection/methods , Hand Sanitizers/administration & dosage , Cross Infection/prevention & control , Europe , Health Surveys , Hospitals/statistics & numerical data , Humans , Point-of-Care Systems/statistics & numerical data
10.
Eur J Clin Microbiol Infect Dis ; 34(9): 1823-6, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26071000

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) is an important human pathogen, and colonisation with this organism can result in localised or systemic infections which may be fatal. One hundred in-patients admitted to a London teaching hospital and 100 out-patients attending prosthetic dentistry clinics were recruited into this study. Of the 100 out-patients, 27 % harboured S. aureus on their dentures, compared to 33 % of in-patients. Only one out-patient had MRSA colonising their dentures whereas 12 % of the in-patients harboured MRSA. The median total bacterial count of the denture plaque samples was 6.2 × 10(7) cfu/sample and 6.9 × 10(7) cfu/sample for the out-patient and in-patient populations, respectively. In most instances, where present, S. aureus comprised less than 1 % of the total viable denture microbiota. Phage typing demonstrated that EMRSA-15 and non-typeable strains were harboured on dentures. The results of this study have revealed that dentures are a potential reservoir of MRSA and so account should be taken of these findings when planning decontamination procedures for elimination of this pathogen.


Subject(s)
Dentures/microbiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/epidemiology , Bacterial Load , Bacteriophage Typing , Humans , Inpatients , Outpatients , Staphylococcal Infections/microbiology
11.
Euro Surveill ; 20(8)2015 Feb 26.
Article in English | MEDLINE | ID: mdl-25742434

ABSTRACT

We present a pilot validation study performed on 10 European Union (EU) Member States, of a point prevalence survey (PPS) of healthcare-associated infections (HAIs) and antimicrobial use in Europe in 2011 involving 29 EU/European Economic Area (EEA) countries and Croatia. A total of 20 acute hospitals and 1,950 patient records were included in the pilot study, which consisted of validation and inter-rater reliability (IRR) testing using an in-hospital observation approach. In the validation, a sensitivity of 83% (95% confidence interval (CI): 79­87%) and a specificity of 98% (95% CI: 98­99%) were found for HAIs. The level of agreement between the primary PPS and validation results were very good for HAIs overall (Cohen's κappa (κ):0.81) and across all the types of HAIs (range: 0.83 for bloodstream infections to 1.00 for lower respiratory tract infections). Antimicrobial use had a sensitivity of 94% (95% CI: 93­95%) and specificity of 97% (95% CI: 96­98%) with a very good level of agreement (κ:0.91). Agreement on other demographic items ranged from moderate to very good (κ: 0.57­0.95): age (κ:0.95), sex (κ: 0.93), specialty of physician (κ: 0.87) and McCabe score (κ: 0.57). IRR showed a very good level of agreement (κ: 0.92) for both the presence of HAIs and antimicrobial use. This pilot study suggested valid and reliable reporting of HAIs and antimicrobial use in the PPS dataset. The lower level of sensitivity with respect to reporting of HAIs reinforces the importance of training data collectors and including validation studies as part of a PPS in order for the burden of HAIs to be better estimated.


Subject(s)
Anti-Bacterial Agents/administration & dosage , Bacterial Infections/epidemiology , Bacterial Infections/etiology , Cross Infection/drug therapy , Cross Infection/epidemiology , Drug Prescriptions/statistics & numerical data , Drug Utilization Review/statistics & numerical data , Anti-Bacterial Agents/therapeutic use , Bacterial Infections/drug therapy , Croatia/epidemiology , Cross Infection/etiology , Cross Infection/microbiology , Drug Resistance, Microbial , Drug Utilization Review/methods , Europe/epidemiology , European Union , Female , Health Surveys , Hospitals/statistics & numerical data , Humans , Male , Middle Aged , Pilot Projects , Prevalence , Reproducibility of Results , Sensitivity and Specificity
12.
J Hosp Infect ; 89(4): 351-6, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25777079

ABSTRACT

Healthcare-associated infection (HCAI), patient safety, and the harmonization of related policies and programmes are the focus of increasing attention and activity in Europe. Infection control training for healthcare workers (HCWs) is a cornerstone of all patient safety and HCAI prevention and control programmes. In 2009 the European Centre for Disease Prevention and Control (ECDC) commissioned an assessment of needs for training in infection control in Europe (TRICE), which showed a substantial increase in commitment to HCAI prevention. On the other hand, it also identified obstacles to the harmonization and promotion of training in infection control and hospital hygiene (IC/HH), mostly due to differences between countries in: (i) the required qualifications of HCWs, particularly nurses; (ii) the available resources; and (iii) the sustainability of IC/HH programmes. In 2013, ECDC published core competencies for infection control and hospital hygiene professionals in the European Union and a new project was launched ['Implementation of a training strategy for infection control in the European Union' (TRICE-IS)] that aimed to: define an agreed methodology and standards for the evaluation of IC/HH courses and training programmes; develop a flexible IC/HH taxonomy; and implement an easily accessible web tool in 'Wiki' format for IC/HH professionals. This paper reviews several aspects of the TRICE and the TRICE-IS projects.


Subject(s)
Cross Infection/prevention & control , Education, Medical, Continuing/methods , Education, Medical, Continuing/organization & administration , Health Personnel , Infection Control/methods , Cross Infection/epidemiology , Europe/epidemiology , Humans
13.
J Hosp Infect ; 90(1): 38-45, 2015 May.
Article in English | MEDLINE | ID: mdl-25648940

ABSTRACT

BACKGROUND: In order to study the micro-epidemiology of meticillin-resistant Staphylococcus aureus (MRSA) effectively, the molecular typing method used must be able to distinguish between different MRSA strains. Pulsed-field gel electrophoresis (PFGE) can detect small genetic differences but is limited in its potential to distinguish isolates within a major lineage. Whole-genome sequencing (WGS) provides sufficient resolution to support or exclude links between otherwise indistinguishable isolates, but lacks the practical utility of conventional typing methods. AIM: To explore the utility of WGS in a hierarchical approach with PFGE to help establish possible sources of MRSA cross-transmission in the intensive care setting. METHODS: Possible transmission routes from donor to recipient via the hands of staff, the air or environmental surfaces were identified. Focused molecular typing used PFGE to explore these transmission hypotheses. WGS was applied when an acquisition event involved a common PFGE pulsotype. FINDINGS: Thirty-eight of the 78 acquisition events could not be explored as clinical isolates were not available. PFGE excluded all potential donors from 26 of the remaining 40 acquisition events, but did identify a probable source in 14 new colonizations. Within the hypotheses tested, PFGE supported links between patients occupying the same bay, the same bed space, adjacent isolation rooms and different wards. When a patient source was not identified, PFGE implicated the ward environment and the hands of staff. However, WGS disproved three of these transmission pathways. CONCLUSION: WGS can complement conventional typing methods by confirming or refuting possible MRSA transmission hypotheses. Epidemiological data are crucial in this process.


Subject(s)
Cross Infection/microbiology , Electrophoresis, Gel, Pulsed-Field/methods , Genome-Wide Association Study/methods , Methicillin-Resistant Staphylococcus aureus/genetics , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Molecular Typing/methods , Staphylococcal Infections/microbiology , Cross Infection/epidemiology , Cross Infection/prevention & control , Hand Hygiene/methods , Hand Hygiene/standards , Humans , Intensive Care Units , London/epidemiology , Methicillin Resistance/genetics , Nasal Cavity/microbiology , Polymorphism, Single Nucleotide , Prospective Studies , Staphylococcal Infections/epidemiology , Staphylococcal Infections/transmission
14.
J Hosp Infect ; 88(4): 213-7, 2014 Dec.
Article in English | MEDLINE | ID: mdl-25441017

ABSTRACT

BACKGROUND: The burden of healthcare-associated infections, such as healthcare-acquired Clostridium difficile (HA-CDI), can be expressed in terms of additional length of stay (LOS) and mortality. However, previous estimates have varied widely. Although some have considered time of infection onset (time-dependent bias), none considered the impact of severity of HA-CDI; this was the primary aim of this study. METHODS: The daily risk of in-hospital death or discharge was modelled using a Cox proportional hazards model, fitted to data on patients discharged in 2012 from a large English teaching hospital. We treated HA-CDI status as a time-dependent variable and adjusted for confounders. In addition, a multi-state model was developed to provide a clinically intuitive metric of delayed discharge associated with non-severe and severe HA-CDI respectively. FINDINGS: Data comprised 157 (including 48 severe) HA-CDI cases among 42,618 patients. HA-CDI reduced the daily discharge rate by nearly one-quarter [hazard ratio (HR): 0.72; 95% confidence interval (CI): 0.61-0.84] and increased the in-hospital death rate by 75% compared with non-HA-CDI patients (HR: 1.75; 95% CI: 1.16-2.62). Whereas overall HA-CDI resulted in a mean excess LOS of about seven days (95% CI: 3.5-10.9), severe cases had an average excess LOS which was twice (∼11.6 days; 95% CI: 3.6-19.6) that of the non-severe cases (about five days; 95% CI: 1.1-9.5). CONCLUSION: HA-CDI contributes to patients' expected LOS and risk of mortality. However, when quantifying the health and economic burden of hospital-onset of HA-CDI, the heterogeneity in the impact of HA-CDI should be accounted for.


Subject(s)
Clostridioides difficile , Cross Infection/mortality , Enterocolitis, Pseudomembranous/mortality , Hospital Mortality , Length of Stay , Adult , Aged , Aged, 80 and over , Humans , Middle Aged , Patient Discharge , Proportional Hazards Models
15.
Euro Surveill ; 19(49)2014 Dec 11.
Article in English | MEDLINE | ID: mdl-25523973

ABSTRACT

The harmonisation of training programmes for infection control and hospital hygiene (IC/HH) professionals in Europe is a requirement of the Council recommendation on patient safety. The European Centre for Disease Prevention and Control commissioned the 'Training Infection Control in Europe' project to develop a consensus on core competencies for IC/HH professionals in the European Union (EU). Core competencies were drafted on the basis of the Improving Patient Safety in Europe (IPSE) project's core curriculum (CC), evaluated by questionnaire and approved by National Representatives (NRs) for IC/HH training. NRs also re-assessed the status of IC/HH training in European countries in 2010 in comparison with the situation before the IPSE CC in 2006. The IPSE CC had been used to develop or update 28 of 51 IC/HH courses. Only 10 of 33 countries offered training and qualification for IC/HH doctors and nurses. The proposed core competencies are structured in four areas and 16 professional tasks at junior and senior level. They form a reference for standardisation of IC/HH professional competencies and support recognition of training initiatives.


Subject(s)
Curriculum/standards , Education, Professional/standards , Health Personnel/education , Infection Control/standards , Consensus Development Conferences as Topic , Europe , European Union , Female , Humans , Infection Control/methods , Male , Patient Safety , Professional Competence/standards
16.
J Antimicrob Chemother ; 69(11): 2886-8, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25213273

ABSTRACT

Antimicrobial resistance is a national and worldwide threat to the future of healthcare. Educating both healthcare staff and the public in the prudent use of antimicrobials is an essential part of antimicrobial stewardship programmes that aim to contain and control resistance and preserve the usefulness of currently available antibiotics. Using current available evidence, regulatory documents and national antimicrobial stewardship guidance for primary and secondary care, five dimensions for antimicrobial prescribing and stewardship competences have been developed in England, through an independent multiprofessional group led by the Advisory Committee on Antimicrobial Resistance and Healthcare Associated Infection (ARHAI) of the Department of Health (England). They are designed to complement the generic competency framework for all prescribers from the UK National Prescribing Centre (now part of National Institute for Health and Care Excellence) and are relevant to all independent prescribers, including doctors, dentists and non-medical practitioners. The antimicrobial prescribing and stewardship competences published jointly by ARHAI and PHE in 2013 are believed to be the first of their kind. Implementation of these competences will be an important contribution to the delivery of the UK government's 5 year Antimicrobial Resistance Strategy.


Subject(s)
Advisory Committees/standards , Anti-Infective Agents/standards , Drug Prescriptions/standards , Program Development/standards , Advisory Committees/trends , Humans , United Kingdom
17.
J Hosp Infect ; 88(3): 149-55, 2014 Nov.
Article in English | MEDLINE | ID: mdl-25146223

ABSTRACT

BACKGROUND: This survey was undertaken after a number of neonatal unit (NNU) outbreaks were reported to the North London health protection teams (HPTs). AIM: To determine the diversity of the outbreaks, ascertain potential sources and contributing factors, and identify the investigative procedures followed and control measures implemented. METHODS: Using a structured questionnaire, information from the HPT database was collected for all NNU outbreaks reported between January 2010 and February 2011. FINDINGS: Ten outbreaks were identified from seven hospitals in 14 months. There was one para-influenza outbreak, seven Staphylococcus aureus [including six meticillin-resistant S. aureus (MRSA)] outbreaks, and two Gram-negative outbreaks. Potential sources of transmission identified for the MRSA outbreaks were healthcare worker (HCW)-assisted transmission (N = 2) and mother-to-baby transmission with onward HCW-assisted transmission (N = 3). An environmental source with onward HCW-assisted transmission was documented for one of the Gram-negative outbreaks. Interventions included patient screening and enhanced cleaning (N = 10), isolating/cohorting affected neonates (N = 9), barrier nursing (N = 6), staff movement restrictions (N = 5), hand hygiene audits (N = 4), staff screening (N = 4), household contact screening (N = 3) and environmental sampling (N = 3). Potential contributing factors included inadequate staffing levels, cluttered unit, inadequate sterilization of communal milk-expressing equipment and inappropriate follow-up of MRSA results. CONCLUSION: This survey determined the diversity of NNU outbreaks in North London, and highlighted the importance of a multi-faceted approach to outbreak control. These data will assist in the development of clinical standards for the prevention, control and reporting of NNU outbreaks, and guidance for best practice in NNUs.


Subject(s)
Cross Infection/epidemiology , Disease Outbreaks , Intensive Care Units, Neonatal , Anti-Bacterial Agents/therapeutic use , Carrier State , Child , Cross Infection/prevention & control , Disease Outbreaks/prevention & control , Disease Outbreaks/statistics & numerical data , Hand Hygiene , Humans , Infant , Infant, Newborn , Infection Control/methods , Infectious Disease Transmission, Professional-to-Patient/statistics & numerical data , London/epidemiology , Risk Factors , Staphylococcal Infections/epidemiology , Surveys and Questionnaires
18.
Euro Surveill ; 19(29)2014 Jul 24.
Article in English | MEDLINE | ID: mdl-25080142

ABSTRACT

Meticillin-resistant Staphylococcus aureus (MRSA) is a major cause of healthcare-associated infections in Europe. Many examples have demonstrated that the spread of MRSA within healthcare settings can be reduced by targeted infection control measures. The aim of this systematic literature analysis and review was to summarise the evidence for the use of bacterial cultures for active surveillance the benefit of rapid screening tests, as well as the use of decolonisation therapies and different types of isolation measures. We included 83 studies published between 2000 and 2012. Although the studies reported good evidence supporting the role of active surveillance followed by decolonisation therapy, the effectiveness of single-room isolation was mostly shown in non-controlled studies, which should inspire further research regarding this issue. Overall, this review highlighted that when planning the implementation of preventive interventions, there is a need to consider the prevalence of MRSA, the incidence of infections, the competing effect of standard control measures (e.g. hand hygiene) and the likelihood of transmission in the respective settings of implementation.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Cross Infection/prevention & control , Infection Control/methods , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin/therapeutic use , Staphylococcal Infections/prevention & control , Cross Infection/microbiology , Cross Infection/transmission , Hand Disinfection , Humans , Infection Control/standards , Methicillin Resistance , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/drug therapy , Staphylococcal Infections/transmission
19.
Clin. Microbiol. Infect ; 20(Suppl 1): 1-55, jan. 2014.
Article in English | BIGG - GRADE guidelines | ID: biblio-965308

ABSTRACT

Healthcare-associated infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB) are a leading cause of morbidity and mortality worldwide. These evidence-based guidelines have been produced after a systematic review of published studies on infection prevention and control interventions aimed at reducing the transmission of MDR-GNB. The recommendations are stratified by type of infection prevention and control intervention and species of MDR-GNB and are presented in the form of 'basic' practices, recommended for all acute care facilities, and 'additional special approaches' to be considered when there is still clinical and/or epidemiological and/or molecular evidence of ongoing transmission, despite the application of the basic measures. The level of evidence for and strength of each recommendation, were defined according to the GRADE approach.


Subject(s)
Humans , Cross Infection , Cross Infection/prevention & control , Cross Infection/transmission , Chlorhexidine , Health Knowledge, Attitudes, Practice , Disease Outbreaks/prevention & control , Risk Factors , Bacterial Typing Techniques , Infection Control , Gram-Negative Bacterial Infections/prevention & control , Gram-Negative Bacterial Infections/transmission , Drug Resistance, Multiple, Bacterial , Hand Hygiene , Gram-Negative Bacteria/isolation & purification , Anti-Infective Agents, Local
20.
Clin Microbiol Infect ; 20 Suppl 1: 1-55, 2014 Jan.
Article in English | MEDLINE | ID: mdl-24329732

ABSTRACT

Healthcare-associated infections due to multidrug-resistant Gram-negative bacteria (MDR-GNB) are a leading cause of morbidity and mortality worldwide. These evidence-based guidelines have been produced after a systematic review of published studies on infection prevention and control interventions aimed at reducing the transmission of MDR-GNB. The recommendations are stratified by type of infection prevention and control intervention and species of MDR-GNB and are presented in the form of 'basic' practices, recommended for all acute care facilities, and 'additional special approaches' to be considered when there is still clinical and/or epidemiological and/or molecular evidence of ongoing transmission, despite the application of the basic measures. The level of evidence for and strength of each recommendation, were defined according to the GRADE approach.


Subject(s)
Cross Infection/prevention & control , Cross Infection/transmission , Disease Outbreaks/prevention & control , Gram-Negative Bacteria/isolation & purification , Gram-Negative Bacterial Infections/prevention & control , Gram-Negative Bacterial Infections/transmission , Infection Control/methods , Anti-Infective Agents, Local , Bacterial Typing Techniques , Chlorhexidine , Drug Resistance, Multiple, Bacterial , Hand Hygiene , Health Knowledge, Attitudes, Practice , Humans , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...